(Q44438583)

3 December 2017

title

Differential cognitive and behavioral effects of topiramate and valproate (English)

1 reference

3 December 2017

1

K. J. Meador

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743236

1 January 2024

2

D. W. Loring

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743236

1 January 2024

author name string

CAPSS-027 Study Group

6

1 reference

3 December 2017

J. F. Hulihan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743236

1 January 2024

M. Kamin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743236

1 January 2024

R. Karim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743236

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

3 December 2017

13 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12743236

full work available at URL

1 January 2024

number of pages

6

1 reference

based on heuristic

inferred from page(s)

https://www.neurology.org/doi/pdfdirect/10.1212/01.WNL.0000063308.22506.19

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

1 January 2024

1 reference

3 December 2017

volume

60

1 reference

3 December 2017

issue

9

1 reference

3 December 2017

page(s)

1483-1488

1 reference

Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults

3 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.

1 January 2024

2

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

1 January 2024

3

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Effects of topiramate on cognitive function

1 January 2024

4

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

1 January 2024

5

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

1 January 2024

6

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. The M88-194 Study Group

1 January 2024

7

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Comparative cognitive effects of carbamazepine and phenytoin in healthy adults

1 January 2024

8

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Effects of carbamazepine and phenytoin on EEG and memory in healthy adults.

1 January 2024

9

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults.

1 January 2024

10

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Differential cognitive effects of carbamazepine and gabapentin.

1 January 2024

11

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Differential cognitive and behavioral effects of carbamazepine and lamotrigine

1 January 2024

12

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Central Anticholinergic Hypersensitivity in Aging

1 January 2024

13

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy

1 January 2024

14

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Development of the quality of life in epilepsy inventory.

1 January 2024

21

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Topiramate titration and tolerability

1 January 2024

23

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

Analysis of clinical trials by treatment actually received: is it really an option?

1 January 2024

25

1 reference

https://api.crossref.org/works/10.1212/01.WNL.0000063308.22506.19

1 January 2024

Identifiers

1 reference

3 December 2017

1 reference